Anti-Nuclear Antibody Test Market Report 2018 added by Data Bridge Market Research explores Global Anti-Nuclear Antibody Test Market size, share and growth with forecast to 2025. Global Anti-Nuclear Antibody Test Market is expected to reach USD 1,964.47 million by 2025 from USD 1,093.40 million in 2017, at a CAGR of 7.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors driving the growth of this market are increasing incidence of autoimmune diseases, rising medical insurance, and rise in government healthcare protection.
Here is the Solution! Click Here For Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-antinuclear-antibody-test-market
Market is further segmented into:
- Product
- Test
- Disease
- End-user
Product (Assay Kits & Reagents, Systems, Software),
Test (Indirect Immunofluorescence, ELISA, Multiplex Testing),
Disease (Systemic Lupus Erythematosus, Sjögren’s Syndrome, Rheumatoid Arthritis, Scleroderma, Polymyositis),
End-User (Hospitals, Clinics, Physician Office Laboratories),
Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
According to the study published on health line, it was found that women are more exposed to autoimmune diseases, with a rating of about 2 to 1 as compared to men. It means 6.4% of women and 2.7% of men. It was also found that lupus affects the African-American and Hispanic people more. The two types of tests that are commonly performed to detect antinuclear antibody test are: Enzyme-linked immunosorbent assay and indirect fluorescent antibody. Around 95% of the antinuclear antibody tests are performed to detect lupus autoimmune disease. It was also observed that about 60% of positive results were shown for systemic sclerosis and 40% of positive results were shown for Sjögren’s syndrome.
Covered in this report
The report covers the present scenario and the growth prospects of the global anti-nuclear antibody test for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Request for Detail Table of Content Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-antinuclear-antibody-test-market
Global anti-nuclear antibody test market is dominated by Alere, Inc., followed by Bio-Rad Laboratories and Thermo Fisher Scientific, Inc. Other players in this market include are Trinity Biotech, Antibodies Inc., EUROIMMUN AG, and Immuno Concepts among others.
ALERE, INC.:
Founded in 2001 and headquartered in Massachusetts, U.S. Alere Inc. operates in rapid diagnostics tests devices. Alere segments are focused on cardiometabolic, infectious disease, and toxicology testing. Alere Inc. offers wide range of diagnostic tests for cardiometabolic disease, and toxicology in the United States and across the globe. The products offered by the company includes rapid diagnostic test systems for diagnosis of point-of-care analyzers and test cassette systems for the blood cholesterol, glucose, and related lipids tests and over-the-counter tests for cholesterol monitoring; blood analysis systems for blood gas, electrolyte, and metabolite testing. The anti-nuclear antibody test products are offered by the test and instruments categories.
Abbott Laboratories acquired Alere which has significantly expanded Abbott’s global diagnostics presence. Alere is operating as a subsidiary of Abbott Laboratories.
BIO-RAD LABORATORIES:
Bio-Rad Laboratories, Inc. founded in 1952 and headquartered in California, U.S. It is engaged in development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. It operates its business through its two business segments life science and clinical diagnostics.
Life Science segment offers the wide range of instruments, software, consumables, reagents, and content for the growing fields of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education.
Clinical Diagnostics offers the wide range of innovative products to clinical laboratories worldwide. It has its global presence in over 35 countries.
THERMO FISHER SCIENTIFIC, INC.:
Thermo Fisher Scientific Inc. founded in 1956 and headquartered at Massachusetts, U.S. The company operates its business through four segments namely, laboratory products & services, life sciences & solutions, analytical instruments & speciality diagnostic. Life sciences solutions provides an extensive portfolio of instruments, reagents and consumables used in medical research and biological, discovery and production of vaccines and new drugs as well as diagnosis of diseases. Analytical instruments segment provides a broad offering of consumables, instruments, software and services that are used for a range of applications in the laboratory, on the production line and in the field. Specialty diagnostics segment provides a wide range of diagnostic test kits, reagents, instruments and associated products used to increase the speed and accuracy of diagnosis.
Any Specific Requirements? Questions? Ask to Our Industry Expert @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-antinuclear-antibody-test-market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/global-antinuclear-antibody-test-market/